Pneumocystis jirovecii pneumonia (PJP) is a serious opportunistic infection associated with substantial morbidity and mortality in patients with rheumatic diseases [1]. However, unlike HIV, oncology, and transplant populations, rheumatology lacks formal guidelines to inform PJP prophylaxis. As a result, prophylaxis decisions in rheumatology have often borrowed risk thresholds from other populations.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with ChuMeng
Contact ChuMeng, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack